Linda J. Metheny-Barlow, Ph.D.
Associate Professor, Radiation Oncology
Comprehensive Cancer Center
Brain Tumor Center of Excellence
alternative medicine, cancer/oncogenesis, cell growth, differentiation,d, cognition/learning, drugs/therapeutic agents pharm, molecular biology/molecular me, women's health issues
Academic: 336-713-7636 | Department: 336-713-3600
Chen W, McMahan CN, Barlow KD, Juarez D, Metheny-Barlow LJ. Identification of p75NTR/TrkB-BDNF axis in breast cancer brain metastasis [abstract]. Cancer Res. 2013;73(3 Suppl):A64.
Arter AA, Metheny-Barlow L, Gallagher PE, Tallant EA. Angiotensin-(1-7) inhibits proliferative and fibrotic signaling mechanisms in triple negative breast cancer [abstract]. In: Proceedings of the 103rd Annual Meeting of the Amerian Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, Illinois. Philadelphia (PA): AACR. 2012;():Abstr 5224.
Vern-Gross TZ, Lawrence JA, Case LD, McMullen KP, Bourland JD, Metheny-Barlow LJ, Ellis TL [deceased], Tatter SB, Shaw EG, Urbanic JJ, Chan MD. Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery
. J Neurooncol. 2012;110(3):381-388.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.